The World Health Summit brings together leading researchers, physicians, government officials, and representatives from industry and civil society worldwide.
Dr. Tedros Adhanom Ghebreyesus has been Director-General of the World Health Organization since 2017. Upon assuming office, he outlined five key priorities for the WHO: universal health coverage; health emergencies; women’s, children’s and adolescents’ health; health impacts of climate and environmental change; and a transformed WHO. Tedros is globally recognized as a health scholar, researcher, and diplomat with first-hand experience in research, operations, and leadership in emergency responses to epidemics. He previously served as Ethiopia’s Minister of Foreign Affairs, Ethiopia’s Minister of Health, and Chair of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
Dr Svetlana Akselrod is Director of the World Health Organization (WHO) Global Noncommunicable Diseases (NCD) Platform, and leads a coordinated multisectoral and multi-stakeholder action in the fight against major killers of our time – NCDs. The Global NCD Platform brings together the UN Inter-Agency Task Force on NCDs and the Global Coordination Mechanism on NCDs, and oversees a number of other cross-cutting initiatives on NCDs at global, regional and country levels. Prior to that, Dr Akselrod held the position of WHO’s Assistant Director-General for NCDs and Mental Health, leading WHO’s work in tackling NCDs and their major risk factors. She led the preparatory process for the Third United Nations General Assembly High-level Meeting on NCDs, coordinated the work of the WHO Independent High-level Commission on NCDs and co-chaired the WHO Civil Society Working Group on NCDs. Before joining WHO, Dr Akselrod served for more than 11 years in high-level roles at the Ministry of Health of the Russian Federation, holding the position of Deputy Director at the Department of International Cooperation and Public Affairs. Among Dr Akselrod’s key professional achievements were the inclusion of NCDs, HIV/AIDS, tuberculosis, maternal and child health, antimicrobial resistance and malaria as key priorities in the national and international agendas of the Russian Federation.
Bill Anderson is the CEO of Roche Pharmaceuticals. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Bill serves as a member of Roche's Executive Committee, overseeing the Pharmaceutical division. Leading an organisation of 55,000 people, he is passionate about helping people make meaningful progress every day on the things that matter to patients. With a world-leading investment in R&D, his vision is to bring more medical advances to patients at less cost to society. His tenure at Roche has seen him serve as the CEO of Genentech, the Head of Global Product Strategy and in roles leading the US Oncology and Immunology business units. Bill has a bachelor's degree in chemical engineering from the University of Texas and earned masters degrees in management and chemical engineering from the Massachusetts Institute of Technology.
Ricardo Baptista Leite MP, MD is a Medical Doctor (ID-trained), member of Portuguese Parliament (Health and Foreign Affairs Committees) and National Spokesperson for Health of Social Democratic Party. He is the President of ‘UNITE – Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and Other Infectious Diseases’; a global platform of parliamentarians committed to ending HIV/AIDS, viral hepatitis and other infectious diseases as global health threats by 2030. He is one of six people acknowledged globally by ‘The Economist’ as a ‘HCV Change Maker’ and is the Head of Public Health at Católica University of Portugal, Coordinator of Sustainable Healthcare at NOVA Information Management School and Guest Lecturer at NOVA Medical School. He has also served as the former Deputy Mayor of the city of Cascais.
Francesca Colombo, M.Sc., is Head of the Health Division at the Organisation for Economic Cooperation. She is responsible for OECD work on health, which aims at providing internationally comparable data on health systems and applying economic analysis to health policies, advising policy makers, stakeholders and citizens on how to respond to demands for more and better health care and make health systems more people centred. Major activities under her responsibility cover the response to the COVID-19 crisis and solutions to make health systems more resilient; trends in health spending; measuring of health care outcomes, activities and inputs; health care quality policies; assessing health system efficiency and value for money; health workforce; long-term care systems and ageing; the economics of public health; pharmaceutical policies, new technologies, big data and Artificial Intelligence in health. Major publications resulting from the work of the Division she manages include Health at a Glance, Health in the 21st Century: Putting Data to Work for Stronger Health Systems, Realising the Full Potential of Primary Health Care, Attracting and Retaining Care Workers for the Elderly, Tackling Wasteful Spending on Health, The Heavy Burden of Obesity, Making Mental Health Count. Mrs Colombo has over 20 years of experience leading international activities on health and health systems. Over her career, she travelled extensively in Europe, South America and Asia, advising governments on health system policies and reforms.
Dame Sally is UK Special Envoy on Antimicrobial Resistance. Before this, she was Chief Medical Officer (CMO) for England and Chief Medical Adviser to the UK government from March 2011 to September 2019, having held the post on an interim basis since June 2010. Dame Sally advocates globally on AMR. She has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side event in 2016. She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and was for three years the chair of the WHO Strategic and Technical Advisory Group on AMR. Most recently, Dame Sally has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016. Dame Sally was a member of the World Health Organization (WHO) Executive Board 2014-2016 and has led delegations to a range of WHO summits and forums since 2004.
Christian Drosten is the Director of the Institute of Virology of the Charité - Universitätsmedizin Berlin. He has become an internationally respected COVID-19 expert. In 2003 he discovered the unknown virus causing SARS and developed a diagnostic test that enabled public health authorities worldwide to stop a beginning pandemic. Drosten has co-authored more than 300 peer-reviewed papers and coordinated research consortia funded by the European Union, Deutsche Forschungsgemeinschaft, and the German Ministry of Research. He is a member of the internal advisory board of the German Center for Infection Research (DZIF) and the speaker of the German National Research Network for Zoonotic Infections. He received the German Federal Cross of Merit for his work to counter the SARS epidemic.
Jeremy Farrar is Director of the Wellcome Trust, a global charitable foundation (both politically and financially independent) which exists to improve health for everyone by helping great ideas to thrive. Jeremy is a clinician scientist who before joining Wellcome was, for eighteen years, Director of the Clinical Research Unit in Viet Nam, where his research interests were in infectious diseases, tropical health and emerging infections. He has contributed to almost 600 peer-reviewed scientific papers and served on several global advisory committees. In 2015 he was recognised by Fortune magazine as 12th in the top 50 of the World’s Greatest Leaders.
Henrietta H. Fore has been UNICEF’s Executive Director since 2018. She has worked to champion economic development, education, health, humanitarian assistance and disaster relief in a public service, private sector and non-profit leadership career that spans more than four decades. She has previously served as Administrator for USAID and Director of United States Foreign Assistance, Undersecretary of State for Management at the US Department of State, Director of the United States Mint in the US Department of Treasury, and Chair of the Board and Chief Executive Officer of Holsman International, a manufacturing and investment company.
Roland Göhde is Chairman of the Board at GHA - German Health Alliance, an initiative of BDI - Federation of German Industries, jointly established with the German government in the year 2010, and he is Senior Managing Director of the German diagnostics and biotechnology company Sysmex Partec. Before, he had the position as HIV/AIDS Project Coordinator at Partec, subsequently as Director of the Partec Essential Healthcare Division and from 2000 to 2014 as Managing Partner. Göhde is a Member of the UNAIDS Health Innovation Exchange Advisory Board, the World Health Summit Council, the Management Board of the German-African Business Association 'Afrika-Verein', the Board of the BDI Committee on the healthcare industry, and Chair of the Private Sector Advisory Board of GIZ. In addition, he is the main initiator of the 'Action Group on Ebola' and the 'German-African Healthcare Symposium' launched in 2014. Göhde has been active as Chairman of the Board of the Free State of Saxony biotechnology/life sciences association 'biosaxony' from 2009 to 2016. From 2012 to 2014 he acted as Founding Member of the Advisory Board of the Coordinating Agency for the Free State of Saxony Healthcare Sector. Roland Göhde is Co-Founder and Member of the Board of the charitable Göhde Foundation, established in 2012.
Charles Gore is the Executive Director of the Medicines Patent Pool. He took up the post in July 2018 following a career in patient representation and public health advocacy. He has advanced the work of the MPP in HIV and Hepatitis and is opening up further opportunities for the MPP model of voluntary licensing to be used for patented medicines on the World Health Organization (WHO) essential medicines list. Following his own diagnosis with hepatitis C in 1995 and cirrhosis in 1998, Charles set up The Hepatitis C Trust (2002) and the European Liver Patients Assocation (2004). In 2007, Charles organized an international meeting of hepatitis patient organisations to agree on co-ordinated global action, which led to the annual World Hepatitis Day and a new NGO, The World Hepatitis Alliance, of which Charles was the first president. As a result of the Alliance's advocacy, the WHO adopted successive viral hepatitis resolutions, making World Hepatitis Day an official day (28 July) and endorsing the first Global Health Sector Strategy on viral hepatitis to eliminate hepatitis B and C by 2030. Charles also sits on a number of national and international advisory bodies, including the WHO Director-General’s Strategic and Technical Advisory Committee for Viral Hepatitis and has been a member of all WHO guideline development groups on testing and treating viral hepatitis.
Prof. Ilona Kickbusch’s work focuses on the political determinants of health, health in all policies, and global health. She established the Global Health Centre at the Graduate Institute and served as its director until 2019. She advises countries on global health strategies and trains health specialists and diplomats in global health diplomacy. Among other positions, Kickbusch is a member of the Global Preparedness Monitoring Board and the WHO High-Level Independent Commission on NCDS and is co-chair of UHC 2030. She acts as Council Chair to the World Health Summit in Berlin. She has had a distinguished career with the WHO and chairs the international advisory board for the development of the German global health strategy.
On 1 December 2019, Ms Kyriakides became the European Commissioner for Health and Food Safety. In the area of health, she is leading the Commission’s work on Europe’s Beating Cancer Plan, to help improve cancer prevention and care and is in charge of developing a new Pharmaceutical Strategy to ensure that Europe has enough affordable medicines to meet its needs. Her responsibilities also include supporting Member States in improving the quality and sustainability of health systems, creating a European Health Data Space to promote health-data exchange and support research. She is also in charge of ensuring full implementation of the European One Health Action Plan against Antimicrobial Resistance and working towards a global agreement on antimicrobials. Her responsibilities also include ensuring enforcement of animal welfare laws and promoting European standards globally as well as ensuring enforcement of EU laws on food safety and animal and plant health and leading the work to protect plant health, reduce dependency on pesticides and support low-risk and non-chemical alternatives. During the COVID-19 crisis, she has been leading the Commissions work to coordinate the EU’s health response and support Member States to tackle the outbreak.
Mariana Mazzucato (PhD) is Professor in the Economics of Innovation and Public Value at University College London (UCL), where she is Founding Director of the UCL Institute for Innovation & Public Purpose (IIPP). She received her BA from Tufts University and her MA and PhD from the Graduate Faculty of the New School for Social Research. She advises policy makers around the world on innovation-led inclusive and sustainable growth. Her current roles include being Chair of the World Health Organization's Council on the Economics of Health for All and a member of the Scottish Government’s Council of Economic Advisors, the South African President’s Economic Advisory Council, the OECD Secretary General’s Advisory Group on a New Growth Narrative, the UN High Level Advisory Board for Economic and Social Affairs, Argentina’s Economic and Social Council, Vinnova’s Advisory Panel in Sweden, and Norway’s Research Council. Previously, through her role as Special Advisor for the EC Commissioner for Research, Science and Innovation (2017-2019), she authored the high-impact report on Mission-Oriented Research & Innovation in the European Union, turning “missions” into a crucial new instrument in the European Commission’s Horizon innovation program.
John G. Meara, MD, DMD, MBA is the Kletjian Professor of Global Surgery, Director of the Program in Global Surgery and Social Change, and Professor of Surgery in the Department of Surgery at Harvard Medical School. Dr. Meara serves as the Plastic Surgeon-in-Chief of the Department of Plastic & Oral Surgery at Boston Children's Hospital. He was Co-Chair for the Lancet Commission on Global Surgery and was a commissioner on the Lancet Global Health Commission on High Quality Health Systems in the SDG Era and the Lancet Oncology Commission. In 2008 he created the Paul Farmer Global Surgery Fellowship program. He is also interested in value-based health care and implementation science research, including time driven activity-based cost research and outcomes research. Dr. Meara has led several ICHOM projects focusing on outcomes reporting and international benchmarking.
Dr. Bernd Ohnesorge, PhD, is President of Europe, Middle East and Africa (EMEA) of Siemens Healthineers. Previously, he had served for four years as head of the Magnetic Resonance Business Unit. Dedicated to the advancement of medical technologies, he previously held several leading positions at Siemens including the position of the head of the X-Ray Imaging Products Business Unit in 2010 and 2011 as well as the leadership position of Siemens Healthcare in China and North-East Asia from 2006 to 2010.
He joined Siemens after the completion of his master’s degree in data communication and digital signal processing at the University of Erlangen in 1994. While serving in several R&D and management positions within the Computed Tomography Business Unit between 1994 and 2006, he finished his PhD thesis on methods for cardiac CT imaging in June 2002 at the Institute of Clinical Radiology of the Ludwig-Maximilian-University in Munich, Germany.
Vikram Patel is a professor of global health and social medicine and psychiatrist whose work over the past two decades has focused on reducing the treatment gap for mental disorders in low resource countries. He is Pershing Professor of Global Health and Social Medicine at the Department of Global Health and Social Medicine of Harvard Medical School in Boston and was awarded a Wellcome Trust Principal Research Fellowship in 2015. He is the Co-Founder and former Director of the Centre for Global Mental Health at the London School of Hygiene and Tropical Medicine (LSHTM), Co-Director of the Centre for Control of Chronic Conditions at the Public Health Foundation of India, and the Co-Founder of Sangath, an Indian NGO dedicated to research in the areas of child development, adolescent health, and mental health. In April 2015, he was listed as one of the world's 100 most influential people by TIME magazine.
Axel R. Pries is a Professor of Physiology and Dean of the Charité - Universitätsmedizin Berlin. His major research fields are microcirculation, organ perfusion, endothelial function, endothelial surface, vascular adaptation, angiogenesis, tumor microcirculation and blood rheology.
Mr. Sy was Secretary General of the International Federation of Red Cross and Red Crescent Societies (IFRC) from 2014 to 2019. He currently serves as Chair of the Board of the Kofi Annan Foundation and Co-Chair of the Global Preparedness Monitoring Board. Prior to his leadership role at the IFRC, Mr. Sy was UNICEF’s Director of Partnerships and Resource Development in New York. He has also served as UNICEF Regional Director for Eastern and Southern Africa and Global Emergency Coordinator for the Horn of Africa. Mr. Sy held leadership positions with the United Nations Development Programme in New York, with the Global Fund to fight AIDS, Tuberculosis and Malaria and with UNAIDS. Before joining the United Nations, Mr. Sy served as Director of Health and Development Programmes with Environment and Development Action in the Third World in Dakar, Senegal.
Ursula von der Leyen is a German politician and has been the first female President of the European Commission since December 2019. She is a member of the Christian Democratic Union (CDU) and the European People's Party (EPP). She has previously served in the federal government of Germany as Federal Minister of Defence, Federal Minister of Labor and Social Affairs as well as Federal Minister for Family Affairs, Senior Citizens, Women and Youth.